Salzin®
Sulfasalazine
Disease Modifying Anti-Rheumatic Drug
Anti inflammatory role: It inhibits theenzymatic activity of Cycloxygenase, Lypoxygenase and PAF synthesis. Immunosuppressiverole: Promotes the release of adenosine, which impairs leukocyte function and activation. It interferes with IL-1, IL-2, and TNF-alpha synthesis.Salzin® is indicated in Mild to moderate Ulcerative Colitis, Juvenile Arthritis, Idiopathic Arthritis, ankolysing arthritis, Psoriatic arthritis.
Week 1: 500 mg OD, Week 2: 500 mg BD, Week 3: 500 mg in the morning and 1000 mg in the evening. , Maintenance Dose: 1000 mg BD.
Salzin® 500tablet: Box containing 10 x 10 tablets in blister pack.